MIGENIX INC has a total of 70 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are HANMI PHARMACEUTICAL CO LTD, DANISHEFSKY SAMUEL J and AERPIO PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 19 | |
#2 | EPO (European Patent Office) | 12 | |
#3 | Australia | 7 | |
#4 | Canada | 5 | |
#5 | China | 5 | |
#6 | Hong Kong | 5 | |
#7 | Republic of Korea | 4 | |
#8 | Israel | 3 | |
#9 | WIPO (World Intellectual Property Organization) | 3 | |
#10 | Japan | 2 | |
#11 | Mexico | 2 | |
#12 | EAPO (Eurasian Patent Organization) | 1 | |
#13 | New Zealand | 1 | |
#14 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry | |
#5 | Macromolecular chemistry and polymers | |
#6 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Dugourd Dominique | 24 |
#2 | Boyd Vincent A | 15 |
#3 | Cameron Dale R | 14 |
#4 | Borders Donald B | 13 |
#5 | Curran William V | 11 |
#6 | Leese Richard A | 11 |
#7 | Jia Qi | 10 |
#8 | Wacowich-Sgarbi Shirley A | 10 |
#9 | Sgarbi Paulo W M | 9 |
#10 | Chen Yuchen | 8 |
Publication | Filing date | Title |
---|---|---|
US2008171783A1 | Compositions and methods for treating hyperproliferative disease | |
CA2613354A1 | Non-nucleoside anti-hepacivirus agents and uses thereof | |
KR20070102741A | Compositions and methods for treating or preventing flaviviridae infections | |
KR20070061879A | Combination anti-viral compositions comprising castanospermine and methods of use | |
CN101014341A | Compositions and methods for treating or preventing hepadnaviridae infection | |
US2005239112A1 | Methods and processes for attaching compounds to matrices | |
CA2530063A1 | Compositions of lipopeptide antibiotic derivatives and methods of use thereof | |
AU2002328203B2 | Antimicrobial and anti-inflammatory peptides | |
US6946261B1 | Efficient methods for producing anti-microbial cationic peptides in host cells | |
EP1174439A2 | Compositions and methods for treating infections using analogues of indolicidin |